Tax or exercise withholding
Wayne Markowitz
CVP, JAPAC
Common Stock
- Value context
- $30.8K
- Reported price
- $86.77 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Edwards Lifesciences Corp
Last 30 daysNo qualifying insider buying. Sales: $54.17K by 1 insider.
Showing the first 6 of 20 trades on this page.
CVP, JAPAC
Common Stock
CVP, JAPAC
Common Stock
SVP, Corporate Controller
Common Stock
CVP, TMTT, Surgical & IHFM
Common Stock
CVP, TAVR
Common Stock
CVP, TAVR
Employee Stock Option (Right to Acquire)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CVP, TMTT, Surgical & IHFM
Common Stock
CVP, TMTT, Surgical & IHFM
Employee Stock Option (Right to Acquire)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CVP, TAVR
Common Stock
CVP, TAVR
Employee Stock Option (Right to Acquire)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CVP, JAPAC
Common Stock
CVP, JAPAC
Employee Stock Option (Right to Acquire)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CEO
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
CEO
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
CVP, EMEACLA
Common Stock
CVP, Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CVP, Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CVP, Chief Financial Officer
Employee Stock Option (Right to Acquire)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CVP, Chief Financial Officer
Performance Rights
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CVP, TAVR
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CVP, JAPAC | Common StockExercise-price or tax withholding | 355$86.77 / share | $30.8K | Sep 11Filed Sep 14 · 3d later | SEC filing |
| CVP, JAPAC | Common StockExercise-price or tax withholding | 568$84.37 / share | $47.92K | Sep 14Filed Sep 14 · 0d later | SEC filing |
| SVP, Corporate Controller | Common StockExercise-price or tax withholding | 253$84.37 / share | $21.35K | Sep 13Filed Sep 14 · 1d later | SEC filing |
| CVP, TMTT, Surgical & IHFM | Common StockExercise-price or tax withholding | 398$86.77 / share | $34.53K | Sep 11Filed Sep 11 · 0d later | SEC filing |
| CVP, TAVR | Common StockOption exercise or conversion10b5-1 | 619$72.68 / share | $44.99K | Sep 11Filed Sep 11 · 0d later | SEC filing |
| CVP, TAVR | Employee Stock Option (Right to Acquire)Option exercise or conversion10b5-1 | Derivative units619$72.68 exercise / conversion price | Not a separate purchase | Sep 11Filed Sep 11 · 0d later | SEC filing |
| CVP, TMTT, Surgical & IHFM | Common StockOption exercise or conversion | 31,800$72.68 / share | $2.31M | Aug 26Filed Aug 26 · 0d later | SEC filing |
| CVP, TMTT, Surgical & IHFM | Employee Stock Option (Right to Acquire)Option exercise or conversion | Derivative units31,800$72.68 exercise / conversion price | Not a separate purchase | Aug 26Filed Aug 26 · 0d later | SEC filing |
| CVP, TAVR | Common StockOption exercise or conversion10b5-1 | 619$72.68 / share | $44.99K | Aug 11Filed Aug 11 · 0d later | SEC filing |
| CVP, TAVR | Employee Stock Option (Right to Acquire)Option exercise or conversion10b5-1 | Derivative units619$72.68 exercise / conversion price | Not a separate purchase | Aug 11Filed Aug 11 · 0d later | SEC filing |
| CVP, JAPAC | Common StockOption exercise or conversion | 9,628$74.02 / share | $712.66K | Jul 28Filed Jul 28 · 0d later | SEC filing |
| CVP, JAPAC | Employee Stock Option (Right to Acquire)Option exercise or conversion | Derivative units9,628$74.02 exercise / conversion price | Not a separate purchase | Jul 28Filed Jul 28 · 0d later | SEC filing |
| CEO | Common StockGift | 320Gift · no purchase price | Not a purchase | Jul 27Filed Jul 27 · 0d later | SEC filing |
| CEO | Common StockGift | 320Gift · no purchase price | Not a purchase | Jul 27Filed Jul 27 · 0d later | SEC filing |
| CVP, EMEACLA | Common StockExercise-price or tax withholding | 109$92.21 / share | $10.05K | Jul 11Filed Jul 13 · 2d later | SEC filing |
| CVP, Chief Financial Officer | Common StockGrant or award | 87,595Award · no purchase price | Non-cash award | Jul 9Filed Jul 10 · 1d later | SEC filing |
| CVP, Chief Financial Officer | Common StockGrant or award | 12,325Award · no purchase price | Non-cash award | Jul 9Filed Jul 10 · 1d later | SEC filing |
| CVP, Chief Financial Officer | Employee Stock Option (Right to Acquire)Grant or award | Derivative units61,800Award · no purchase price | Non-cash award | Jul 9Filed Jul 10 · 1d later | SEC filing |
| CVP, Chief Financial Officer | Performance RightsGrant or award | Derivative units12,325Award · no purchase price | Non-cash award | Jul 9Filed Jul 10 · 1d later | SEC filing |
| CVP, TAVR | Common StockOption exercise or conversion10b5-1 | 619$72.68 / share | $44.99K | Jul 10Filed Jul 10 · 0d later | SEC filing |
Showing the latest 20 of 110 trades. Show all 110 trades
Edwards Lifesciences Corporation Common Stock · Stock
The filing reports a purchase for the member.
Edwards Lifesciences Corporation Common Stock (EW) · Stock
The filing reports a sale for a joint account.
Josh GottheimerReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.